Ferring B.V.
13 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 5 name spellings.
34
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 6 to 20, 2026 · next Dec 6
- 2 fees due Jan 9 to 28, 2027 · next Jan 9
- 4 fees due Feb 1 to 25, 2027 · next Feb 1
- 4 fees due Mar 5 to 26, 2027 · next Mar 5
- 2 fees due Apr 15 to 22, 2027 · next Apr 15
- 2 fees due May 5 to 28, 2027 · next May 5
- 2 fees due Jun 24 to 30, 2027 · next Jun 24
- 2 fees due Jul 7 to 9, 2027 · next Jul 7
- 2 fees due Aug 4 to 16, 2027 · next Aug 4
- 3 fees due Sep 17 to 19, 2027 · next Sep 17
- 3 fees due Oct 21 to 26, 2027 · next Oct 21
Recent changes
- 2 terms have ended since Aug 23, 2026
- Sep 13 US 11,439,686 Recombinant FSH Composition for Treatment of Infertility · lapsed on the fee record
- Sep 4 US 10,064,920 Method for Controlled Ovarian Stimulation using FSH and hCG · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,858,992 | High drug load mesalazine sachet In force · USPTO record | In force | USPTO record | |
| US 7,795,314 | Protective Role of Semapimod in Necrotizing Enterocolitis In force · High confidence | In force | High confidence | |
| US 8,361,273 | Polyurethane elastomers In force · USPTO record | In force | USPTO record | |
| US 10,105,445 | Hydrophilic polyurethane compositions In force · USPTO record | In force | USPTO record | |
| US 8,802,148 | Microparticles and Method for Their Production In force · High confidence | In force | High confidence | |
| US 8,282,958 | Coating method In force · USPTO record | In force | USPTO record | |
| US D701,615 | Swirling apparatus In force · USPTO record | In force | USPTO record | |
| US 8,148,319 | Peptidic Vasopressin Receptor Agonists In force · High confidence | In force | High confidence | |
| US 8,361,272 | Polyurethane elastomers In force · USPTO record | In force | USPTO record | |
| US 10,548,904 | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 111: 13 patents in force now held by others · 61 lapsed for an unpaid fee · 114 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
18 pending · 6 abandoned · 65 no status recorded
Showing 1 to 10 of 89, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/238,032 | Jun 13, 2025 | No status recorded | |
| 19/200,288 | Compositions and Methods for Controlled Ovarian Stimulation | May 6, 2025 | Pending |
| 19/098,420 | Stable Liquid Gonadotropin Formulation | Apr 2, 2025 | Pending |
| 19/009,834 | Jan 3, 2025 | No status recorded | |
| 18/944,900 | Composition and Method for Delivery of BMP-2 Amplifier/Co-Activator for Enhancement of Osteogenesis | Nov 12, 2024 | Pending |
| 18/940,564 | Nov 7, 2024 | No status recorded | |
| 18/814,230 | Methods of Treating Infertility | Aug 23, 2024 | Pending |
| 18/679,184 | May 30, 2024 | No status recorded | |
| 18/874,466 | Compositions and Methods for Intrauterine Insemination (IUI) | Jul 10, 2023 | Pending |
| 18/208,658 | Activated Carbon Pharmaceutical Compositions | Jun 12, 2023 | Pending |
10 of 89 applications shown.
Pro members see all 89 published applications.